financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Raises Opinion On Shares Of Crown Holdings, Inc. To Strong Buy From Buy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Raises Opinion On Shares Of Crown Holdings, Inc. To Strong Buy From Buy
Nov 25, 2025 10:08 AM

12:50 PM EST, 11/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our 12-month target at $128 on an EV/EBITDA of 9.2x our 2026 EBITDA estimate, below its five-year average of 9.5x. We keep our 2025 EPS view at $7.97 but raise our 2026 EPS by $0.03 to $8.51 and 2027 EPS by $0.07 to $9.32. We upgrade to Strong Buy, as we expect CCK to outperform the broader market in an economic downturn given its defensive profile. We expect strong secular growth as the shift from glass to aluminum containers accelerates, particularly in Europe, evidenced by Q3 European volume growth of 12%, though long-term growth rates are expected in the 4%-5% range. ROIC of 7.9% in the last-12-month period is the highest among sub-industry peers, averaging 4.0% and well above Ball Corp. (3.5%) and O-I Glass (-2.2%). Deleveraging is progressing ahead of schedule, and strong cash generation has enabled its tender offer for 2026 debt maturities, which will reduce ongoing interest payments and WACC. Valuation is compelling, at a 17% discount to its five-year average.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Sell Opinion On Shares Of Heico Corporation
Research Alert: CFRA Keeps Sell Opinion On Shares Of Heico Corporation
May 31, 2024
11:30 AM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $190, up $14, reflects a 45x multiple of projected FY 2025 (Oct.) EPS, above HEI's historical forward average. We lift our FY 2024 EPS estimate...
Research Alert: CFRA Lowers Opinion On Shares Of Paycom Software, Inc. To Buy From Strong Buy
Research Alert: CFRA Lowers Opinion On Shares Of Paycom Software, Inc. To Buy From Strong Buy
May 31, 2024
03:05 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Shares of PAYC are selling off today after the company announced a few executive changes, the most notable one being that Christopher Thomas resigned from his position as Co-CEO of...
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Cooper Companies
Research Alert: CFRA Keeps Hold Opinion On Shares Of The Cooper Companies
May 31, 2024
01:10 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $103, on a forward P/E of 26x our FY 2025 (Oct.) earnings estimate, a modest discount to the company's five-year historic average at...
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
Research Alert: CFRA Retains Hold Opinion On Shares Of Moderna, Inc.
May 31, 2024
01:15 PM EDT, 05/31/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: In line with expectations, Moderna ( MRNA ) secured the FDA approval for its mRNA-based RSV vaccine, mRESVIA(R), today for adults 60 years and older. Following the approval of its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved